CN101584669B - Melphalan freeze-dried powder injection - Google Patents

Melphalan freeze-dried powder injection Download PDF

Info

Publication number
CN101584669B
CN101584669B CN 200910033896 CN200910033896A CN101584669B CN 101584669 B CN101584669 B CN 101584669B CN 200910033896 CN200910033896 CN 200910033896 CN 200910033896 A CN200910033896 A CN 200910033896A CN 101584669 B CN101584669 B CN 101584669B
Authority
CN
China
Prior art keywords
melphalan
valve
freeze
temperature
injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 200910033896
Other languages
Chinese (zh)
Other versions
CN101584669A (en
Inventor
叶东
戴建国
赵俊
戴艳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Aosaikang Pharmaceutical Co Ltd
Original Assignee
Jiangsu Aosaikang Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Aosaikang Pharmaceutical Co Ltd filed Critical Jiangsu Aosaikang Pharmaceutical Co Ltd
Priority to CN 200910033896 priority Critical patent/CN101584669B/en
Publication of CN101584669A publication Critical patent/CN101584669A/en
Application granted granted Critical
Publication of CN101584669B publication Critical patent/CN101584669B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a melphalan freeze-dried powder injection and a preparing method thereof. The prepared melphalan freeze-dried powder injection is used for treating multiple myeloma, oophoroma, polycythemia vera, local malignant melanoma and soft tissue sarcoma. The melphalan freeze-dried powder injection contains melphalan, utilizes the mixed solvent composed of the tert-butyl alcohol andthe injection water in the preparation process, wherein the concentration of the melphalan in the mixed solvents is 10-25 mg/ml; and the volume ratio of the solvents is: 5-50% of tert-butyl alcohol a nd the balance of injection water. The preparation process comprises the following steps: measuring tert-butyl alcohol, adding injection water, mixing evenly, cooling to 2-15 DEG C, heat preserving, adding melphalan, stirring and dripping 0.5 mol hydrochloric acid to dissolve, filtering, filling, plugging, disking, freeze-drying, pressing plug, out box, tying and packing after quality test qualification.

Description

Melphalan freeze-dried powder injection
Technical field
What the present invention relates to is a kind of melphalan freeze-dried powder injection and preparation method thereof, melphalan freeze-dried powder injection by this method preparation can be used as multiple myeloma, ovarian cancer, the true too much disease of property erythrocyte, local malignant melanoma, and the medicine of soft tissue sarcoma.
Background technology
Melphalan be the levo form phenylpropyl alcohol by sour chlormethine, its anticarcinogenic effect is pressed PAM for strong, its mechanism of action is identical with HN2, also is cell cycle nonspecific agent (CCNSA).Oral absorption is abundant, and the back 2 hours blood plasma of taking medicine reaches Gao Xiaodu, keeps in blood plasma active about 6 hours, and 50% the medicine of taking medicine in 24 hours is through homaluria, and wherein 13% is original shape, and metabolite is a hydroxyl derivant and a dihydroxyl derivative.
Injection is used for multiple myeloma, ovarian cancer, the true too much disease of property erythrocyte, local malignant melanoma, and the treatment of soft tissue sarcoma.
Melphalan is that white is to buff powder, be insoluble in water, to light, heat and unstable under moisture conditions, so can only make lyophilized injectable powder, but because melphalan is insoluble in water, need to add acid in the process for preparation and make its salify dissolving, common preparation method melphalan in process for preparation is degraded in a large number, makes curative effect of medication reduce and produce the impurity of initiation toxic and side effects.Existing known technology does not improve the suggestion of above defective yet.
Summary of the invention
The objective of the invention is provides a kind of melphalan freeze-dried powder injection and preparation method thereof at above weak point, can improve the stability of melphalan freeze-dried powder injection greatly by this method, make it in preparation, transportation and storage process, have better stability, avoided the hidden danger of bringing because of drug degradation that curative effect reduces and degraded generation impurity brings for patient's drug safety.
The chemical name of melphalan is: L-3{ is to [two (2-chloroethyl) amido] phenyl } alanine, structural formula is:
Figure G2009100338962D00011
Molecular formula is: C 13H 18Cl 2N 2O 2
Molecular weight is: 305.20.
A kind of melphalan freeze-dried powder injection contains melphalan, and the mixed solvent that uses the tert-butyl alcohol and water for injection to form in process for preparation, and wherein melphalan is 10~25mg/ml in the concentration of mixed solvent, and the volume proportion of solvent is:
The tert-butyl alcohol 5~50%
The water for injection surplus
Total amount 100%.
A kind of melphalan freeze-dried powder injection, the volume proportion of described solvent is:
The tert-butyl alcohol 10~30%
The water for injection surplus
Total amount 100%.
A kind of melphalan freeze-dried powder injection also contains excipient.
A kind of melphalan freeze-dried powder injection, described excipient is selected from mannitol, lactose, dextran and glucose.
A kind of melphalan freeze-dried powder injection, its preparation process is:
Measuring tert-butyl alcohol is put in the container, add water for injection, stir and mix homogeneously, mixed solvent is cooled to 2~15 ℃ and insulation, add melphalan again, the hydrochloric acid that stirs and drip 0.5mol makes its dissolving, after mix homogeneously is treated the intermediate passed examination, deliver in the sterilizing room filtering with microporous membrane through 0.22 μ m to clear and bright with peristaltic pump, fill is in brown cillin bottle, part is butyl rubber bung beyond the Great Wall, sabot; Sabot is treated that the lyophilizing sample puts in the freeze drying box, close chamber door, start, open circulating pump, compressor and plate low temperature valve utilize conduction oil that products temperature is descended, when products temperature reaches-40 ℃, the closing plate low temperature valve, open electrical heating and mix low temperature valve and be provided with automatically, kept this products temperature 2~4 hours, then open condenser valve, when the condenser valve temperature reaches-45 ℃, open vacuum system, the current box vacuum reaches 20Pa when following, begins the sublimation drying that heats up, last baking temperature is 28 ℃, kept this temperature 2~4 hours, after the case vacuum does not have significant change before valve in close, tamponade, outlet, with plastic-aluminum composite cover tying, packing after quality inspection is qualified, promptly.
A kind of melphalan freeze-dried powder injection of the present invention and preparation method thereof, can improve the stability of melphalan freeze-dried powder injection greatly by this method in preparation process, the melphalan freeze-dried powder injection its related substances of preparation is lower, the quality stable homogeneous, moisture drying is thorough, stability in transportation and storage process is better, and curative effect reduction and the degraded also having avoided simultaneously bringing because of drug degradation produce the hidden danger that impurity brings for patient's drug safety.
Preparation technology of the present invention is simple, and is convenient feasible, good reproducibility, and production cost is lower, is easy to realize industrialized great production, thereby can produce considerable economic and social benefit.
The specific embodiment
Further specify the present invention below by embodiment.Should correct understanding be: embodiments of the invention are only used for the present invention is described and provide, rather than limitation of the present invention, so, under method prerequisite of the present invention, simple modifications of the present invention is all belonged to the scope of protection of present invention.
Embodiment 1:
Prescription
Melphalan 50g
Tert-butyl alcohol 400ml
Water for injection adds to 2000ml
Make 1000 bottles altogether
Measuring tert-butyl alcohol is put in the container, add water for injection, stir and mix homogeneously, mixed solvent is cooled to 8 ℃ and insulation, add melphalan again, the hydrochloric acid that stirs and drip 0.5mol makes its dissolving, after mix homogeneously is treated the intermediate passed examination, deliver in the sterilizing room filtering with microporous membrane through 0.22 μ m to clear and bright with peristaltic pump, fill is in brown cillin bottle, part is butyl rubber bung beyond the Great Wall, sabot; Sabot is treated that the lyophilizing sample puts in the freeze drying box, close chamber door, start, open circulating pump, compressor and plate low temperature valve utilize conduction oil that products temperature is descended, when products temperature reaches-40 ℃, the closing plate low temperature valve, open electrical heating and mix low temperature valve and be provided with automatically, kept this products temperature 3 hours, then open condenser valve, when the condenser valve temperature reaches-45 ℃, open vacuum system, the current box vacuum reaches 20Pa when following, begins the sublimation drying that heats up, last baking temperature is 28 ℃, kept this temperature 3 hours, after the case vacuum does not have significant change before valve in close, tamponade, outlet, with plastic-aluminum composite cover tying, packing after quality inspection is qualified, promptly.
Embodiment 2:
Prescription
Melphalan 50g
Mannitol 100g
Tert-butyl alcohol 1200ml
Water for injection adds to 4000ml
Make 1000 bottles altogether
Measuring tert-butyl alcohol is put in the container, add water for injection, stir and mix homogeneously, mixed solvent is cooled to 6 ℃ and insulation, add melphalan and mannitol again, the hydrochloric acid that stirs and drip 0.5mol makes its dissolving, after mix homogeneously is treated the intermediate passed examination, deliver in the sterilizing room filtering with microporous membrane through 0.22 μ m to clear and bright with peristaltic pump, fill is in brown cillin bottle, part is butyl rubber bung beyond the Great Wall, sabot; Sabot is treated that the lyophilizing sample puts in the freeze drying box, close chamber door, start, open circulating pump, compressor and plate low temperature valve utilize conduction oil that products temperature is descended, when products temperature reaches-40 ℃, the closing plate low temperature valve, open electrical heating and mix low temperature valve and be provided with automatically, kept this products temperature 4 hours, then open condenser valve, when the condenser valve temperature reaches-45 ℃, open vacuum system, the current box vacuum reaches 20Pa when following, begins the sublimation drying that heats up, last baking temperature is 28 ℃, kept this temperature 2 hours, after the case vacuum does not have significant change before valve in close, tamponade, outlet, with plastic-aluminum composite cover tying, packing after quality inspection is qualified, promptly.
Embodiment 3:
Prescription
Melphalan 50g
Mannitol 200g
Tert-butyl alcohol 200ml
Water for injection adds to 2000ml
Make 1000 bottles altogether
Measuring tert-butyl alcohol is put in the container, add water for injection, stir and mix homogeneously, mixed solvent is cooled to 2 ℃ and insulation, add melphalan and mannitol again, the hydrochloric acid that stirs and drip 0.5mol makes its dissolving, after mix homogeneously is treated the intermediate passed examination, deliver in the sterilizing room filtering with microporous membrane through 0.22 μ m to clear and bright with peristaltic pump, fill is in brown cillin bottle, part is butyl rubber bung beyond the Great Wall, sabot; Sabot is treated that the lyophilizing sample puts in the freeze drying box, close chamber door, start, open circulating pump, compressor and plate low temperature valve utilize conduction oil that products temperature is descended, when products temperature reaches-40 ℃, the closing plate low temperature valve, open electrical heating and mix low temperature valve and be provided with automatically, kept this products temperature 4 hours, then open condenser valve, when the condenser valve temperature reaches-45 ℃, open vacuum system, the current box vacuum reaches 20Pa when following, begins the sublimation drying that heats up, last baking temperature is 28 ℃, kept this temperature 3 hours, after the case vacuum does not have significant change before valve in close, tamponade, outlet, with plastic-aluminum composite cover tying, packing after quality inspection is qualified, promptly.
Embodiment 4:
Prescription
Melphalan 50g
Mannitol 200g
Tert-butyl alcohol 250ml
Water for injection adds to 5000ml
Make 1000 bottles altogether
Measuring tert-butyl alcohol is put in the container, add water for injection, stir and mix homogeneously, mixed solvent is cooled to 15 ℃ and insulation, add melphalan and mannitol again, the hydrochloric acid that stirs and drip 0.5mol makes its dissolving, after mix homogeneously is treated the intermediate passed examination, deliver in the sterilizing room filtering with microporous membrane through 0.22 μ m to clear and bright with peristaltic pump, fill is in brown cillin bottle, part is butyl rubber bung beyond the Great Wall, sabot; Sabot is treated that the lyophilizing sample puts in the freeze drying box, close chamber door, start, open circulating pump, compressor and plate low temperature valve utilize conduction oil that products temperature is descended, when products temperature reaches-40 ℃, the closing plate low temperature valve, open electrical heating and mix low temperature valve and be provided with automatically, kept this products temperature 2 hours, then open condenser valve, when the condenser valve temperature reaches-45 ℃, open vacuum system, the current box vacuum reaches 20Pa when following, begins the sublimation drying that heats up, last baking temperature is 28 ℃, kept this temperature 4 hours, after the case vacuum does not have significant change before valve in close, tamponade, outlet, with plastic-aluminum composite cover tying, packing after quality inspection is qualified, promptly.
Embodiment 5:
Prescription
Melphalan 50g
Glucose 150g
Tert-butyl alcohol 800ml
Water for injection adds to 2000ml
Make 1000 bottles altogether
Measuring tert-butyl alcohol is put in the container, add water for injection, stir and mix homogeneously, mixed solvent is cooled to 2 ℃ and insulation, add melphalan and glucose again, the hydrochloric acid that stirs and drip 0.5mol makes its dissolving, after mix homogeneously is treated the intermediate passed examination, deliver in the sterilizing room filtering with microporous membrane through 0.22 μ m to clear and bright with peristaltic pump, fill is in brown cillin bottle, part is butyl rubber bung beyond the Great Wall, sabot; Sabot is treated that the lyophilizing sample puts in the freeze drying box, close chamber door, start, open circulating pump, compressor and plate low temperature valve utilize conduction oil that products temperature is descended, when products temperature reaches-40 ℃, the closing plate low temperature valve, open electrical heating and mix low temperature valve and be provided with automatically, kept this products temperature 2 hours, then open condenser valve, when the condenser valve temperature reaches-45 ℃, open vacuum system, the current box vacuum reaches 20Pa when following, begins the sublimation drying that heats up, last baking temperature is 28 ℃, kept this temperature 4 hours, after the case vacuum does not have significant change before valve in close, tamponade, outlet, with plastic-aluminum composite cover tying, packing after quality inspection is qualified, promptly.
Embodiment 6:
Prescription
Melphalan 50g
Glucose 100g
Tert-butyl alcohol 400ml
Water for injection adds to 2000ml
Make 1000 bottles altogether
Measuring tert-butyl alcohol is put in the container, add water for injection, stir and mix homogeneously, mixed solvent is cooled to 6 ℃ and insulation, add melphalan and glucose again, the hydrochloric acid that stirs and drip 0.5mol makes its dissolving, after mix homogeneously is treated the intermediate passed examination, deliver in the sterilizing room filtering with microporous membrane through 0.22 μ m to clear and bright with peristaltic pump, fill is in brown cillin bottle, part is butyl rubber bung beyond the Great Wall, sabot; Sabot is treated that the lyophilizing sample puts in the freeze drying box, close chamber door, start, open circulating pump, compressor and plate low temperature valve utilize conduction oil that products temperature is descended, when products temperature reaches-40 ℃, the closing plate low temperature valve, open electrical heating and mix low temperature valve and be provided with automatically, kept this products temperature 4 hours, then open condenser valve, when the condenser valve temperature reaches-45 ℃, open vacuum system, the current box vacuum reaches 20Pa when following, begins the sublimation drying that heats up, last baking temperature is 28 ℃, kept this temperature 2 hours, after the case vacuum does not have significant change before valve in close, tamponade, outlet, with plastic-aluminum composite cover tying, packing after quality inspection is qualified, promptly.
Embodiment 7:
Prescription
Melphalan 50g
Lactose 50g
Tert-butyl alcohol 1500ml
Water for injection adds to 3000ml
Make 1000 bottles altogether
Measuring tert-butyl alcohol is put in the container, add water for injection, stir and mix homogeneously, mixed solvent is cooled to 8 ℃ and insulation, add melphalan and lactose again, the hydrochloric acid that stirs and drip 0.5mol makes its dissolving, after mix homogeneously is treated the intermediate passed examination, deliver in the sterilizing room filtering with microporous membrane through 0.22 μ m to clear and bright with peristaltic pump, fill is in brown cillin bottle, part is butyl rubber bung beyond the Great Wall, sabot; Sabot is treated that the lyophilizing sample puts in the freeze drying box, close chamber door, start, open circulating pump, compressor and plate low temperature valve utilize conduction oil that products temperature is descended, when products temperature reaches-40 ℃, the closing plate low temperature valve, open electrical heating and mix low temperature valve and be provided with automatically, kept this products temperature 3 hours, then open condenser valve, when the condenser valve temperature reaches-45 ℃, open vacuum system, the current box vacuum reaches 20Pa when following, begins the sublimation drying that heats up, last baking temperature is 28 ℃, kept this temperature 4 hours, after the case vacuum does not have significant change before valve in close, tamponade, outlet, with plastic-aluminum composite cover tying, packing after quality inspection is qualified, promptly.
Embodiment 8:
Prescription
Melphalan 50g
Lactose 100g
Tert-butyl alcohol 600ml
Water for injection adds to 2000ml
Make 1000 bottles altogether
Measuring tert-butyl alcohol is put in the container, add water for injection, stir and mix homogeneously, mixed solvent is cooled to 6 ℃ and insulation, add melphalan and lactose again, the hydrochloric acid that stirs and drip 0.5mol makes its dissolving, after mix homogeneously is treated the intermediate passed examination, deliver in the sterilizing room filtering with microporous membrane through 0.22 μ m to clear and bright with peristaltic pump, fill is in brown cillin bottle, part is butyl rubber bung beyond the Great Wall, sabot; Sabot is treated that the lyophilizing sample puts in the freeze drying box, close chamber door, start, open circulating pump, compressor and plate low temperature valve utilize conduction oil that products temperature is descended, when products temperature reaches-40 ℃, the closing plate low temperature valve, open electrical heating and mix low temperature valve and be provided with automatically, kept this products temperature 34 hours, then open condenser valve, when the condenser valve temperature reaches-45 ℃, open vacuum system, the current box vacuum reaches 20Pa when following, begins the sublimation drying that heats up, last baking temperature is 28 ℃, kept this temperature 3 hours, after the case vacuum does not have significant change before valve in close, tamponade, outlet, with plastic-aluminum composite cover tying, packing after quality inspection is qualified, promptly.
Embodiment 9:
Prescription
Melphalan 50g
Dextran 10 0g
Tert-butyl alcohol 800ml
Water for injection adds to 2000ml
Make 1000 bottles altogether
Measuring tert-butyl alcohol is put in the container, add water for injection, stir and mix homogeneously, mixed solvent is cooled to 2 ℃ and insulation, add melphalan and dextran again, the hydrochloric acid that stirs and drip 0.5mol makes its dissolving, after mix homogeneously is treated the intermediate passed examination, deliver in the sterilizing room filtering with microporous membrane through 0.22 μ m to clear and bright with peristaltic pump, fill is in brown cillin bottle, part is butyl rubber bung beyond the Great Wall, sabot; Sabot is treated that the lyophilizing sample puts in the freeze drying box, close chamber door, start, open circulating pump, compressor and plate low temperature valve utilize conduction oil that products temperature is descended, when products temperature reaches-40 ℃, the closing plate low temperature valve, open electrical heating and mix low temperature valve and be provided with automatically, kept this products temperature 2 hours, then open condenser valve, when the condenser valve temperature reaches-45 ℃, open vacuum system, the current box vacuum reaches 20Pa when following, begins the sublimation drying that heats up, last baking temperature is 28 ℃, kept this temperature 2 hours, after the case vacuum does not have significant change before valve in close, tamponade, outlet, with plastic-aluminum composite cover tying, packing after quality inspection is qualified, promptly.
Embodiment 10:
Prescription
Melphalan 50g
Dextran-20 0g
Tert-butyl alcohol 500ml
Water for injection adds to 5000ml
Make 1000 bottles altogether
Measuring tert-butyl alcohol is put in the container, add water for injection, stir and mix homogeneously, mixed solvent is cooled to 8 ℃ and insulation, add melphalan and dextran again, the hydrochloric acid that stirs and drip 0.5mol makes its dissolving, after mix homogeneously is treated the intermediate passed examination, deliver in the sterilizing room filtering with microporous membrane through 0.22 μ m to clear and bright with peristaltic pump, fill is in brown cillin bottle, part is butyl rubber bung beyond the Great Wall, sabot; Sabot is treated that the lyophilizing sample puts in the freeze drying box, close chamber door, start, open circulating pump, compressor and plate low temperature valve utilize conduction oil that products temperature is descended, when products temperature reaches-40 ℃, the closing plate low temperature valve, open electrical heating and mix low temperature valve and be provided with automatically, kept this products temperature 3 hours, then open condenser valve, when the condenser valve temperature reaches-45 ℃, open vacuum system, the current box vacuum reaches 20Pa when following, begins the sublimation drying that heats up, last baking temperature is 28 ℃, kept this temperature 4 hours, after the case vacuum does not have significant change before valve in close, tamponade, outlet, with plastic-aluminum composite cover tying, packing after quality inspection is qualified, promptly.
Embodiment 11:
Respectively prepare melphalan freeze-dried powder injection respectively by embodiment 1~10, check its outward appearance, visible foreign matters, particulate matter, content, related substance and moisture more respectively, it the results are shown in Table 1.
Table 1 melphalan freeze-dried powder injection check result

Claims (1)

1. melphalan freeze-dried powder injection is characterized in that each proportion of raw materials is:
Melphalan 50g
Mannitol 200g
Tert-butyl alcohol 200ml
Water for injection adds to 2000ml
Make 1000 bottles altogether
And be prepared as follows:
Measuring tert-butyl alcohol is put in the container, add water for injection, stir and mix homogeneously, mixed solvent is cooled to 2 ℃ and insulation, add melphalan and mannitol again, the hydrochloric acid that stirs and drip 0.5mol makes its dissolving, after mix homogeneously is treated the intermediate passed examination, deliver in the sterilizing room filtering with microporous membrane through 0.22 μ m to clear and bright with peristaltic pump, fill is in brown cillin bottle, part is butyl rubber bung beyond the Great Wall, sabot; Sabot is treated that the lyophilizing sample puts in the freeze drying box, close chamber door, start, open circulating pump, compressor and plate low temperature valve utilize conduction oil that products temperature is descended, when products temperature reaches-40 ℃, the closing plate low temperature valve, open electrical heating and mix low temperature valve and be provided with automatically, kept this products temperature 4 hours, then open condenser valve, when the condenser valve temperature reaches-45 ℃, open vacuum system, the current box vacuum reaches 20Pa when following, begins the sublimation drying that heats up, last baking temperature is 28 ℃, kept this temperature 3 hours, after the case vacuum does not have significant change before valve in close, tamponade, outlet, with plastic-aluminum composite cover tying, packing after quality inspection is qualified, promptly.
CN 200910033896 2009-06-19 2009-06-19 Melphalan freeze-dried powder injection Expired - Fee Related CN101584669B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200910033896 CN101584669B (en) 2009-06-19 2009-06-19 Melphalan freeze-dried powder injection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200910033896 CN101584669B (en) 2009-06-19 2009-06-19 Melphalan freeze-dried powder injection

Publications (2)

Publication Number Publication Date
CN101584669A CN101584669A (en) 2009-11-25
CN101584669B true CN101584669B (en) 2010-12-29

Family

ID=41369242

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200910033896 Expired - Fee Related CN101584669B (en) 2009-06-19 2009-06-19 Melphalan freeze-dried powder injection

Country Status (1)

Country Link
CN (1) CN101584669B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104994847A (en) * 2012-10-26 2015-10-21 肿瘤多肽股份公司 Lyophilized preparations of melphalan flufenamide

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101856325A (en) * 2010-06-11 2010-10-13 上海丽思化工科技有限公司 Hydrochloric acid melphalan injection liquid and preparation method thereof
AR077384A1 (en) * 2010-07-05 2011-08-24 Eriochem Sa AN INJECTABLE PHARMACEUTICAL FORMULATION OF MELFALANO.
PL2701720T3 (en) 2011-04-28 2017-12-29 Oncopeptides Ab Lyophilized preparation of cytotoxic dipeptides
HUE047813T2 (en) * 2012-10-26 2020-05-28 Oncopeptides Ab Lyophilized preparations of melphalan flufenamide
CN103920148B (en) * 2014-04-24 2016-06-22 山东新华医疗器械股份有限公司 A kind of freeze drying process of monoclonal antibody formulation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101204366A (en) * 2007-11-29 2008-06-25 济南帅华医药科技有限公司 Melphalan sustained-release implant treating for solid tumor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101204366A (en) * 2007-11-29 2008-06-25 济南帅华医药科技有限公司 Melphalan sustained-release implant treating for solid tumor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104994847A (en) * 2012-10-26 2015-10-21 肿瘤多肽股份公司 Lyophilized preparations of melphalan flufenamide

Also Published As

Publication number Publication date
CN101584669A (en) 2009-11-25

Similar Documents

Publication Publication Date Title
CN101584669B (en) Melphalan freeze-dried powder injection
CN101584670B (en) Decitabine freeze-dried powder injection
CN101606934B (en) Bendamustine hydrochloride compound
CN101584668A (en) Bendamustine hydrochloride freeze-dried powder injection
CN100560061C (en) A kind of Lornoxicam freeze-dried injection and preparation method thereof
CN101537012B (en) Complex vitamin freeze-dried powder injection and preparation method thereof
CN101564381A (en) Gemcitabine hydrochloride lyophilized powder injection
CN100563633C (en) Hydrochloric acid diltiazem freeze-dried powder injection for injections and preparation method thereof
CN101711746B (en) Ganciclovir freeze-dry preparation for injection and preparation method thereof
CN103054863B (en) Pharmaceutical composition of omeprazole sodium, and preparation method of pharmaceutical composition
CN106420635A (en) Spectinomycin hydrochloride and lincomycin hydrochloride freeze-dried powder injection and preparation method of spectinomycin hydrochloride and lincomycin hydrochloride freeze-dried powder injection
CN104257615B (en) A kind of dezocine freeze-drying medicinal composition and preparation method thereof
CN102038939B (en) Preparation method of adenosine triphosphate coenzyme insulin freeze-dried powder injection
CN101632679A (en) Composite vitamin for injection and preparation method thereof
CN103877032B (en) Vecuronium bromide pharmaceutical composition for injection and preparation method thereof
CN115530373A (en) Health food suitable for diabetic patients and preparation method thereof
CN102670524B (en) Pantoprazole sodium freeze-dried preparation for injection and preparation method thereof
CN107913252A (en) A kind of growth hormone release inhibiting hormone powder-injection composition and its preparation process
CN103860482A (en) Bendamustine hydrochloride freeze-dried powder injection preparation method, product prepared through method, and use of product
CN103655489A (en) Epirubicin hydrochloride pharmaceutical composition and preparation method thereof
CN103655490A (en) Idarubicin hydrochloride pharmaceutical composition and preparation method thereof
CN104173300A (en) Preparation method of bendamustine hydrochloride freeze-dried injection
CN104688766B (en) Polysaccharide sulphate for injection powder-injection pharmaceutical composition and preparation method
CN103191153B (en) Muscular amino acid and nucleoside extract and pharmaceutical composition thereof
CN103599079B (en) Injection lobaplatin pharmaceutical composition and its preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP01 Change in the name or title of a patent holder

Address after: 211112 Jiangsu Province, Nanjing City, Jiangning Science Park Road No. 699

Patentee after: Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Address before: 211112 Jiangsu Province, Nanjing City, Jiangning Science Park Road No. 699

Patentee before: Jiangsu Aosaikang Pharmaceutical Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101229

Termination date: 20160619